Urgent

Fabry disease acute crisis

Inborn error · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

X-linked lysosomal storage disorder (alpha-galactosidase A deficiency) with episodic severe neuropathic pain crises (acroparaesthesiae) and multisystem (renal, cardiac, cerebrovascular) involvement.

Red flags

  • Stroke / TIA symptoms
  • Cardiac arrhythmia
  • Progressive renal impairment
  • Severe intractable pain

Assessment

Differential diagnosis

  • Peripheral neuropathy (other)
  • Erythromelalgia
  • Vasculitis
  • Sickle cell crisis
  • Complex regional pain syndrome

Investigations

  • Assess for triggers (fever, exertion, temperature change)
  • Renal and cardiac assessment
  • Alpha-galactosidase A activity / genetics (diagnosis)
  • ECG and echocardiography
  • Neuroimaging if stroke-like symptoms

Management

  • Provide adequate analgesia for the pain crisis
  • Identify and remove triggers
  • Assess renal, cardiac and cerebrovascular status
  • Refer to metabolic / specialist services
  • Optimise enzyme replacement or chaperone therapy (specialist)
  • Manage organ complications

Drugs & doses

Neuropathic pain agents / analgesia
Enzyme replacement therapy (specialist, chronic)
Organ-directed therapy

Disposition

Analgesia and specialist referral; admit if organ complication.

Complications & pitfalls

  • Chronic kidney disease
  • Cardiomyopathy / arrhythmia
  • Stroke
  • Chronic pain

Exam pearls

  • Consider Fabry in a young person with unexplained neuropathic pain, stroke or proteinuria.
  • It is a multisystem disease; assess heart, kidneys and brain.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.